Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In idiopathic pulmonary fibrosis, the quantitation of disease severity using pulmonary function tests is often confounded by emphysema. We have identified the composite physiologic index (CPI) most closely reflecting the morphologic extent of pulmonary fibrosis. Consecutive patients with a clinical/computed tomography (CT) diagnosis of idiopathic pulmonary fibrosis (n = 212) were divided into group I (n = 106) and group II (n = 106). The CPI was derived in group I (by fitting pulmonary function tests against disease extent on CT) and was tested in Group II. The formula for the CPI was as follows: extent of disease on CT = 91.0 − (0.65 × percent predicted diffusing capacity for carbon monoxide [DLCO]) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1). In group II, the CPI correlated more strongly with disease extent on CT (r2 = 0.51) than the individual pulmonary function test (DLCO the highest value, r2 = 0.38). A subanalysis demonstrated that the better fit of the CPI was ascribable to a correction of the confounding effects of emphysema. Mortality was predicted more accurately by the CPI than by a pulmonary function test in all clinical subgroups, including a separate cohort of 36 patients with histologically proven usual interstitial pneumonia (CPI, p < 0.0005; FVC, p = 0.002; PO2, p = 0.002). In conclusion, a new CPI, derived against CT and validated using split sample testing, is a more accurate prognostic determinant in usual interstitial pneumonia than an individual pulmonary function test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the Composite Physiologic Index (CPI) and the Gender-Age-Physiology (GAP) index have been most commonly applied for estimating the survival of patients with IPF [3–6].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
In the citing paper
“CPI quantifies pulmonary function impairment due to pulmonary fibrosis, which is then correlated with the extent of fibrosis in computed tomography while excluding emphysema [3].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Austin, J. H., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Remy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Self-citationHistopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
Self-citationIdeal Alveolar Air and the Analysis of Ventilation-Perfusion Relationships in the Lungs
Riley, R. L., & Cournand, A. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.12.825 · Cited by 563
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Research works printed but not linked: 7
- 1995, Am J Respir Crit Care Med, 151, 1180
- 1997, Arthritis Rheum, 40, 1229
- 1983, Clin Respir Physiol, 19, 1
- 1994, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044 · DOI · Paper page
- 1983, Am Rev Respir Diagn, 2, 43
- 1976, Chest, 69, 263
- 1995, Am J Respir Crit Care Med, 151, 1180
Cited by
Items 501–600 of 705
Predictors of mortality of idiopathic pulmonary fibrosis.
Carbone, R. G., Balleari, E., Grosso, M., Montanaro, F., Bottino, G., & Ghio, R. (2008) · PubMed · Cited by 7
A score for estimating survival in idiopathic pulmonary fibrosis with rest SpO2>88.
Soares, M. R., Pereira, C. A. D. C., Ferreira, R. G., Coletta, E. N. A. M., Lima, M. S., & Storrer, K. M. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 10
Caminati, A., & Harari, S. A. (2005) · PubMed · Cited by 7
Takei, R., Arita, M., Tokioka, F., Tachibana, H., Tokumasu, H., & Ishida, T. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.11.70 · Cited by 6
Idiopathische interstitielle Pneumonien
Müller-Mang, C., Stiebellehner, L., Schmid, K., & Bankier, A. A. (2007) · Der Radiologe · doi:10.1007/s00117-006-1457-5 · Cited by 6
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_33 · Cited by 6
Kahai, R., Castelli, G., Danzo, F., Ferreira, L., Srirangan, A., Morviducci, M., Mirabelli, F. M., Kaenmuang, P., Roberts, C., Bax, S., et al. (2025) · CHEST Journal · doi:10.1016/j.chest.2025.09.021 · Cited by 5
Self-citationIdiopathic Interstitial Pneumonias
Selman, M., Morrison, L. D., Noble, P. W., & King, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00057-2 · Cited by 8
Polat, G., Özdemir, Ö., Ermin, S., Unat, D. S., & Üçsular, F. D. (2024) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v41i2.13779 · Cited by 5
Idiopathic Pulmonary Fibrosis: The Epidemiology and Natural History of Disease
Tourin, O., Swigris, J. J., & Olson, A. L. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_2 · Cited by 5
Ikeda, M., Oga, T., Chen-Yoshikawa, T. F., Tokuno, J., Oto, T., Okawa, T., Okada, Y., Akiba, M., Tanaka, S., Yamada, Y., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01715-x · Cited by 5
Biomarkers in Idiopathic Pulmonary Fibrosis
Stankovic, S. D., Stjepanović, M., & Ašanin, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100042 · Cited by 6
External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis
Zhang, X., Ren, Y., Xie, B., Wang, S., Geng, J., He, X., Jiang, D., He, J., Luo, S., Wang, X., et al. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13564 · Cited by 6
Nicholson, A. G., & Rice, A. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139018760.013 · Cited by 5
Self-citationSarcoïdose pulmonaire : aspects cliniques et modalités thérapeutiques
Uzunhan, Y., Jeny, F., Crockett, F., Piver, D., Kambouchner, M., Valeyre, D., & Nunès, H. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.01.010 · Cited by 5
Current best clinical practices for monitoring of interstitial lung disease
Bendstrup, E. M., Kronborg-White, S. B., Møller, J., & Prior, T. S. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2162504 · Cited by 7
“the gender, age and physiology (ILD-GAP) index and the composite physiology index (CPI) [89,90].”
BackgroundSato, R., Handa, T., Tanizawa, K., & Hirai, T. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02795-9 · Cited by 5
“%] in the patient group vs. 14 [23.3”
BackgroundMethodInfluentialInterstitial Disease in Systemic Sclerosis
Goh, N. S. L., & du Bois, R. M. (2004) · Technical report · doi:10.1016/s1571-5078(04)02010-0 · Cited by 7
Self-citationPulmonary Function Tests in Idiopathic Pulmonary Fibrosis
Bonella, F., Marco, F. D., & Spagnolo, P. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_5 · Cited by 5
Quantifying Fibrosis in Fibrotic Lung Disease: A Good Human Plus a Machine Is the Best Combination?
Wells, A. U., & Walsh, S. L. F. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202311-954ed · Cited by 5
“Moreover, the composite physiologic index (CPI), a pulmonary function formula representing the optimal fi t of PFTs against the visual extent of fi brosis (8), strongly predicted mortality independently of the DTA extent score in multivariable analysis.”
BackgroundSelf-citationDeep learning in interstitial lung disease: classification and prognostic insights
Wang, Y., Shang, Y., Yao, J., Li, H., Kui, X., Zhao, W., & Liu, J. (2024) · Radiology Science · doi:10.15212/radsci-2023-0011 · Cited by 5
“The Composite Physiologic Index has a straightforward structure composed primarily of spirometric volumes and the diffusing capacity of the lung for carbon monoxide [35].”
BackgroundUyama, M., Handa, T., Uozumi, R., Hashimoto, S., Taguchi, Y., Ikezoe, K., Tanizawa, K., Tanabe, N., Oguma, T., Matsunashi, A., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-03075-8 · Cited by 4
“Although a direct comparison is unavailable, a substantial proportion of the bronchial areas labeled by AIQCT may have been included in the ILD areas in the visual scoring and CALIPER evaluations, as suggested in the original articles [8, 10].”
InfluentialFermoyle, C. C., Mackintosh, J. A., Navaratnam, V. V., Ellis, S. J., Cooper, W. A., Goh, N. S. L., Moodley, Y. P., Reynolds, P. N., Zappala, C. J., Hopkins, P. M.-A., et al. (2026) · Respirology · doi:10.1002/resp.70246 · Cited by 4
“Patient characteristics, including composite physiologic index (CPI) [15] and gender, age, and lung physiology (GAP) index [16], are detailed in Table 1.”
Self-citationPugashetti, J. V., Kim, J. S., Combs, M. P., Ma, S., Adegunsoye, A., Linderholm, A., Strek, M. E., Chen, C., Dilling, D. F., Whelan, T. P. M., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.03.018 · Cited by 4
Bozkuş, F., & Keskin, O. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195874 · Cited by 6
Non-pharmacological treatment of idiopathic pulmonary fibrosis
Adamali, H. I., Anwar, M., Russell, A., & Egan, J. J. (2012) · Current Respiratory Care Reports · doi:10.1007/s13665-012-0031-z · Cited by 5
“was constructed against the morphological severity of the disease in order to calibrate disease severity using PFTs in isolation [24].”
The Keys to Making a Confident Diagnosis of IPF
Wadhwa, A., & Flaherty, K. R. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_5 · Cited by 4
Sato, R., Handa, T., Matsumoto, H., Hirai, K., Ohkura, N., Kubo, T., & Hirai, T. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6716-20 · Cited by 4
“34×percentage of predicted forced expiratory volume in 1 second (FEV1)] (16).”
BackgroundPatrucco, F., Albera, C., Bellan, M., Zava, M., Gavelli, F., Balbo, P. E., & Solidoro, P. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107370 · Cited by 4
Combined pulmonary fibrosis and emphysema
Jen, R., & Ryerson, C. J. (2013) · Current Respiratory Care Reports · doi:10.1007/s13665-013-0059-8 · Cited by 4
“The limitations of single variables for use in prognostication of IPF have led to evaluation of composite measures of progression that include a combination of clinical and physiological variables [23–26].”
BackgroundMethodMartino, M. D., Cobuccio, R., Bruzzese, D., Rea, G., Meoli, I., Stefanelli, F., Canora, A., Capaccio, A., Sanduzzi, A., Matarese, A., et al. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 4
Salvador-Corres, I., Quirant‐Sánchez, B., Teniente‐Serra, A., Centeno, C., Moreno, A., Rodríguez-Pons, L., Serra, P., García-Núñez, M., Martínez-Cáceres, E. M., Rosell, A., et al. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2020.08.020 · Cited by 4
Nolan, C. M., Schofield, S. J., Maddocks, M. M., Patel, S., Barker, R. E., Walsh, J. A., Polgar, O., George, P. M., Molyneaux, P. L., Maher, T. M., et al. (2023) · Respirology · doi:10.1111/resp.14494 · Cited by 4
Classification, natural history and staging of idiopathic pulmonary fibrosis.
Poletti, V. E., & Egan, J. J. (2013) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 5
Chaudhary, N. I., Luettich, K., Peck, M. J., Pierri, E., Felber-Medlin, L., Vuillaume, G., Leroy, P., Hoeng, J., & Peitsch, M. C. (2017) · F1000Research · doi:10.12688/f1000research.11698.1 · Cited by 4
Risk Factors and Biomarkers of RA-ILD
Doyle, T. J., Dellaripa, P. F., & Rosas, I. O. (2017) · Respiratory medicine · doi:10.1007/978-3-319-68888-6_5 · Cited by 4
Soumagne, T., Quétant, S., Guillien, A., Falque, L., Hess, D. J., Aguilaniu, B., & Degano, B. (2023) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2023.101042 · Cited by 3
Pérez, E. R. F., Humphries, S. M., Lynch, D. A., Moua, T., Chaudhary, S., Adams, T. N., Adegunsoye, A., Scholand, M. B., Sood, N., & Vestal, B. (2026) · Annals of the American Thoracic Society · doi:10.1093/annalsats/aaoag116 · Cited by 3
Wells, A. U., Ward, S. P., & Cramer, D. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9771-5_5 · Cited by 3
Self-citationUpdate in Imaging of Idiopathic Pulmonary Fibrosis
Kaproth-Joslin, K. A., Croake, M. F., & Hobbs, S. (2020) · Advances in Clinical Radiology · doi:10.1016/j.yacr.2020.04.004 · Cited by 3
Older Patients With Interstitial Lung Disease Feature a Distinct Clinical Profile
Martínez‐Martínez, L., Orozco, S., Alonso, A., Millan‐Billi, P., Barril, S., Ruibal, G., Francesqui, J., Lobo-Prat, D., Giménez, A., López-Vilaró, L., et al. (2024) · Open Respiratory Archives · doi:10.1016/j.opresp.2024.100374 · Cited by 4
Su, N., Hou, F. F., Zhu, H., Ma, J., & Liu, F. (2024) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001693 · Cited by 3
Advances in management of pulmonary fibrosis
Lachowicz, J. A., Steinfort, D., Smallwood, N., & Prasad, J. D. (2025) · Internal Medicine Journal · doi:10.1111/imj.70051 · Cited by 3
Casillo, V., Cerri, S., Ciervo, A., Stendardo, M., Manzoli, L., Flacco, M. E., Manno, M., Bocchino, M., Luppi, F., & Boschetto, P. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0930-7 · Cited by 3
Lung Function in Asthma, Chronic Obstructive Pulmonary Disease, and Lung Fibrosis
Janssens, W., & Bleyenbergh, P. V. (2020) · Wiley eBooks · doi:10.1002/9781118597309.ch37 · Cited by 3
Manzetti, G. M., Hosein, K., Cecchini, M. J., Kwan, K. F., Abdelrazek, M., Zompatori, M., Rogliani, P., & Mura, M. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01753-7 · Cited by 3
“current standard of care (individual pulmonary function tests, 6MWD, HRCT chest scan fibrosis score) and with other multi-dimensional scores as well, namely GenderAge-Physiology (GAP) Index [14], CPI (both original and CALIPER-revised versions) [15, 16] and Mortality Risk Scoring System (MRSS) [17].”
BackgroundMethodThe Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V., & Cordier, J.-F. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2401-6_22 · Cited by 4
Combined Pulmonary Fibrosis and Emphysema and Digital Clubbing
Rasul, T. F., Bergholz, D. R., ROVINSKI, R., Gulraiz, S., & Fonts, E. (2022) · Cureus · doi:10.7759/cureus.24231 · Cited by 3
“Many studies have shown that the forced vital capacity and total lung capacity are usually within normal ranges, but the DLCO is diminished significantly.”
BackgroundInfluentialInterstitial lung diseases: an overview
Karampitsakos, Τ., Wijsenbeek, M. S., Herazo‐Maya, J. D., Τzouvelekis, Α., & Kreuter, M. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10017322 · Cited by 3
Jeong, Y. J., Lynch, D. A., Rho, J. Y., Hamzeh, N. Y., & Suh, Y. J. (2016) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000198 · Cited by 3
Lung Transplantation in Interstitial Lung Disease
Kim, C., CORDOVA, F. C., & Toyoda, Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-49918-5_5 · Cited by 3
Jutant, E., Price, L., Wort, S. J., Humbert, M. J. C., & Montani, D. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10005815 · Cited by 3
Risk prediction and end-points in idiopathic pulmonary fibrosis: one step at a time
Ryerson, C. J. (2014) · European Respiratory Journal · doi:10.1183/09031936.00021814 · Cited by 3
Nakagawa, H., Ogawa, E., Fukunaga, K., Kinose, D., Yamaguchi, M., Nagao, T., Tanaka-Mizuno, S., & Nakano, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226214 · Cited by 3
Resende, A. C. L., Cordero, S., Mancuzo, E. V., Storrer, K. M., Moreira, M. A. C., Baptista, F. M. D. A., Ferreira, R. G., Soares, M. R., & Pereira, C. (2025) · Cureus · doi:10.7759/cureus.80290 · Cited by 2
“DLCO is the functional variable that best correlates with disease extent in IPF and is also the variable that most reliably predicts survival at baseline [41,42].”
Gunne, E., Holden, S., Franciosi, A. N., Keane, M., McCarthy, C., & Doran, P. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088271 · Cited by 2
Suvorova, O., Трушенко, Н. В., Lavginova, B. B., Levina, I. A., Chikina, S. Y., Мержоева, З. М., Nekludova, G. V., & Avdeev, S. N. (2025) · Journal of Thoracic Disease · doi:10.21037/jtd-2025-1042 · Cited by 2
Hewitt, R. J., Chakravarty, P., Perez-Lloret, J., Banchero, M., Berg, M., van den Berge, M., Traves, W. J., Yates, L. L., Walker, S. A., Gaboriau, D. C. A., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.01273-2025 · Cited by 2
“Disease extent was determined through calculation of composite physiological index (CPI) derived from lung function values [27], and scoring of high-resolution computed tomography (HRCT) scans as described previously [28] (table 1 and supplementary table S1).”
Self-citationKishaba, T., Higa, M., & Nagano, H. (2025) · Cureus · doi:10.7759/cureus.99813 · Cited by 2
“The ASCEND and INPULSIS trials demonstrated that antifibrotic therapies reduce the rate of FVC decline and delay time to acute exacerbation or death [2,26].”
InfluentialSex Differences in IPF: Data from the German INSIGHTS Registry
Leuschner, G., Prasse, A., Klotsche, J., Kreuter, M., Wirtz, H. R. W., Pittrow, D., Frankenberger, M., Behr, J., & the INSIGHTS-IPF registry Investigators (2026) · Respiration · doi:10.1159/000550309 · Cited by 2
“To control for the potential influence of emphysema on physiological parameters in the multivariate mortality analysis, we analyzed the composite physiologic index (CPI), an index designed to adjust for emphysema by integrating FVC, DLCO, and FEV1 [16].”
Okamoto, M., Fujimoto, K., Chikasue, T., Yanagihara, T., Tabata, K., Zaizen, Y., Tominaga, M., Sumi, A., Takeoka, H., Matsuo, N., et al. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.12.005 · Cited by 2
Feng, X., Zeng, W., Lv, X., Liang, B., & Ou, X. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113862 · Cited by 2
“…et al. proposed to evaluate the severity of fibrosis by using the composite physiological index (CPI) in patients with pulmonary fibrosis and emphysema, which can provide more powerful prognostic information and more accurate overall assessment than individual pulmonary function parameters [42,43].”
Behr, J., Prasse, A., Wirtz, H., Koschel, D., Pittrow, D., Held, M., Klotsche, J., Andreas, S., Claussen, M., Grohé, C., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.00570-2025 · Cited by 2
Maher, T. M., Jenkins, G. R., Saini, G., Braybrooke, R., Johnson, S. R., Chua, F., Lukey, P. T., Simpson, J. K., Allen, R. J., Wain, L. V., et al. (2026) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2025-003763 · Cited by 2
Nathan, S. D. (2005) · Current Opinion in Organ Transplantation · doi:10.1097/01.mot.0000169367.38261.34 · Cited by 2
Salajka, F., Bartoš, V., Novosad, J., Šťásek, J., Bis, J., Brtko, M., Polanský, P., Koblížek, V., & Sedlák, V. (2015) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2011.218 · Cited by 2
“The parameters of FVC and TLCO were also used to construct the composite physiological index (CPI), which was originally developed with the aim of expressing the disease severity according to the extent of the disease on the CT [26].”
MethodCPFE: distinctive and non-distinctive features
Wells, A. U., Margaritopoulos, G. A., Antoniou, K. M., Nunès, H., & Costabel, U. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10005915 · Cited by 2
Self-citationYoussuf, H. A. A., Sabry, Y. Y., El-Hafeez, A. M. A., & Mohamed, H. A. (2016) · Egyptian Journal of Bronchology · doi:10.4103/1687-8426.193633 · Cited by 2
KONEVA, O. A., Desinova, O., Ananyeva, L. P., & Ковалева, Н. В. (2018) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.14412/1995-4484-2018-591-599 · Cited by 2
Idiopathic Pulmonary Fibrosis: Phenotypes and Comorbidities
King, C. S., Aryal, S., & Nathan, S. D. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_11 · Cited by 3
Nakagawa, H., Otoshi, R., Isomoto, K., Katano, T., Baba, T., Komatsu, S., Hagiwara, E., Nakano, Y., Kuwahira, I., & Ogura, T. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01254-z · Cited by 2
Park, M. S. (2020) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2020.0100 · Cited by 3
Advances in predicting patient survival in pulmonary sarcoidosis
Kırkıl, G., Lower, E. E., & Baughman, R. P. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.1925107 · Cited by 2
“The Walsh model of a composite score integrating the composite physiologic index (CPI) .[78] with radiologic information including the mean pulmonary artery diameter/ascending aorta diameter (MPAD/AAD) [72] and the presence of >20% fibrosis on high-resolution computer tomography (HRCT) [70].”
MethodClinical evaluation on idiopathic pulmonary fibrosis.
Shen, Q., & Peng, H. (2021) · PubMed Central · doi:10.11817/j.issn.1672-7347.2021.190402 · Cited by 3
Development of a nomogram for predicting the presence of combined pulmonary fibrosis and emphysema
Yuan, X., Jin, J., & Xu, X. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01725-x · Cited by 2
“Hypertension 85 (41.9) 33 (41.3) 52 (42.3) 0.885 Reflux esophagitis 39 (18.9) 17 (20.2) 22 (18.0) 0.691 Coronary disease 65 (31.9) 27 (33.3) 38 (30.9) 0.715 Diabetes 50 (24.4) 19 (23.5) 31 (25.0) 0.801 Osteoporosis 22 (10.8) 7 (8.5) 15 (12.3) 0.396 Chronic kidney diseases 15 (7.4) 4 (4.9) 11 (9.1) 0.270 Stroke 33 (16.…”
MethodInfluentialIdiopathic Pulmonary Fibrosis: The Epidemiology and Natural History of Disease
Mohning, M. P., Swigris, J. J., & Olson, A. L. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_2 · Cited by 2
Estrategias de interpretación de las pruebas de función pulmonar
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Lázaro, F. B., Casaburi, R. H., Coates, A. L., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2007) · Archivos de Prevención de Riesgos Laborales · Cited by 2
Idiopathic pulmonary fibrosis: The current state of the problem
Shmelev, E. I. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh20168812103-108 · Cited by 2
Novel exploratory data in interstitial lung disease
Wells, A. U. (2019) · Respirology · doi:10.1111/resp.13621 · Cited by 2
Self-citationOn Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
Spagnolo, P., & Oldham, J. M. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0474ed · Cited by 2
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study.
Bocchino, M., Brancaccio, G., Rea, G., Martino, M. D., Gaeta, G. B., & Sanduzzi, A. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 1
Patil, S. V., & Toshniwal, S. (2023) · Global Journal of Health Sciences and Research · doi:10.25259/gjhsr_14_2023 · Cited by 1
1 H-NMR urine metabolomic fingerprint for severity discrimination in pulmonary sarcoidosis
Jeny, F., Triba, M. N., Chauveau, S., Valeyre, D., Mokhtari, S., Nunès, H., Bernaudin, J., & Savarin, P. (2025) · ERJ Open Research · doi:10.1183/23120541.00763-2024 · Cited by 1
“The CPI was originally developed to assess idiopathic pulmonary fibrosis, another fibrotic interstitial lung disease [29].”
Prognosis and prognostic factors for chronic fibrosing idiopathic interstitial pneumonias
Nishikiori, H., & Chiba, H. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.06.005 · Cited by 2
Huang, T., Hou, H.-Y., Chang, H.-Y., Hu, C., Kuo, H.-I., Er, H., Wu, Y.-W., Lin, C., Tseng, Y., Wang, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32619-1 · Cited by 1
“The Td-AUC and C-index of the BMP index were then compared with several recently reported categorical prognostic predictors, including GAP stages 28 , monocyte counts 29 , neutrophil to lymphocyte ratio (NLR) 30 , lymphocyte to monocyte ratio (LMR) 31 , the composite physiologic index (CPI) 32,33 , the clinical physio…”
InfluentialMortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I
Ramos, D., Francesqui, J., Bollo, E., Villar, A., Flórez, P., Balcells, E., Castaño, G., Pinillos‐Robles, E. J., Mayoral, R. G., López-Muñíz, B., et al. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108591 · Cited by 1
Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis
Mackintosh, J. A., Walsh, S. L. F., Silva, M., Calandriello, L., Humphries, S. M., Lynch, D. A., Jo, H., Glaspole, I., Grainge, C., Goh, N. S. L., et al. (2026) · Respirology · doi:10.1002/resp.70196 · Cited by 2
Self-citationZhou, H., Li, J., Zhong, R., Zhang, Y., Zhou, Y., He, H., & Sun, Z. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1768803 · Cited by 1
Podolanczuk, A. J., Mulder, H., Kim, J. S., Neely, M. L., Kaner, R. J., & Todd, J. L. (2026) · Respiratory Research · doi:10.1186/s12931-026-03511-x · Cited by 1
“Linear regression models were used to assess associations between HDL-C, ApoA1 and PON-1 levels and measures of disease severity (FVC % predicted, DLco % predicted, composite physiologic index [CPI] [12], and gender-age-physiology [GAP] index) [13] at enrollment.”
Kaenmuang, P., Goldman, N. R., Srirangan, A., Danzo, F., Yip, W. H., Taki, A., Boreland, S., Vitri, B., Stock, C. J. W., Denton, C. P., et al. (2025) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/dvur8b · Cited by 1
“In our cohort, Caucasian ethnicity was associated with a higher likelihood of nintedanib interruption, but only in the multivariable model adjusted for CPI.”
InfluentialSelf-citationWang, X., & Xu, Y. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15156035 · Cited by 1
“The CPI was used to describe overall pulmonary function status in patients with IPF [11].”
Gwon, H. R., Lee, J., Chung, M. P., Jeong, S. H., Song, J. W., Lee, J. H., Lee, H. L., Choi, S. M., Kim, Y. H., Park, S. W., et al. (2026) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2026.08.001 · Cited by 1
Otaola, M., Quadrelli, S., Tabaj, G. C., Molinari, L., & Boscio, V. D. (2011) · CHEST Journal · doi:10.1378/chest.1118639 · Cited by 1
Integration of Clinical Findings and Physiology in Respiratory Disease
Kishaba, T. (2015) · Journal of Respiratory Research · Cited by 1
Tomioka, K. T. H. (2014) · Internal Medicine Open Access · doi:10.4172/2165-8048.1000138 · Cited by 1
“[7] developed a severity variable, the composite physiologic index (CPI) that reconciles functional severity and the global morphologic extent of IPF.”
BackgroundMethodControversies in Fibrosis and Emphysema
Antoniou, K. M., Bibaki, E., & Margaritopoulos, G. A. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2017.04.012 · Cited by 1
Τzouvelekis, Α., Tzilas, V., Papiris, S. A., & Bouros, D. E. (2017) · Respiration · doi:10.1159/000478910 · Cited by 1
Idiopathic Interstitial Pneumonias
Ryu, J. H., Selman, M., Colby, T. V., & King, T. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00063-4 · Cited by 2
Self-citationAriani, A., Sverzellati, N., Becciolni, A., Milanese, G., & Silva, M. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1858053 · Cited by 2
Wells, A. U., & Хирани, Н. (2009) · PULMONOLOGIYA · doi:10.18093/0869-0189-2009-4-11-57 · Cited by 2
Self-citation
Metadata
- Authors
- Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M.
- Affiliations
- Mayo Clinic (US)
- Department of Radiology and Department of Physiology Royal Brompton Hospital, Interstitial Lung Disease Unit; Department of Radiology, King's College Hospital, London, United Kingdom; and Department of Pathology, Mayo Clinic, Scottsdale, Arizona
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 167
- Issue
- 7
- Pages
- 962-969
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3022958008
- Cited by
- 686
- References
- 32
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 48 · 2020: 42 · 2019: 40 · 2018: 40 · 2017: 52 · 2016: 47 · 2015: 42 · 2014: 27 · 2013: 38 · 2012: 22
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, usual interstitial pneumonia, composite physiologic index, pulmonary function tests, diffusing capacity for carbon monoxide, mortality prediction, prognostic score
- MeSH terms
- Aged, Biopsy, Carbon Monoxide, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Lung, Male, Middle Aged, Monitoring, Physiologic, Predictive Value of Tests, Prognosis, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Fibrosis, Statistics as Topic, Tomography, X-Ray Computed, Total Lung Capacity, Vital Capacity, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.